Dysregulated systemic metabolism in a Down syndrome mouse model
Objective: Trisomy 21 is one of the most complex genetic perturbations compatible with postnatal survival. Dosage imbalance arising from the triplication of genes on human chromosome 21 (Hsa21) affects multiple organ systems. Much of Down syndrome (DS) research, however, has focused on addressing ho...
Saved in:
Main Authors: | Dylan C. Sarver (Author), Cheng Xu (Author), Leandro M. Velez (Author), Susan Aja (Author), Andrew E. Jaffe (Author), Marcus M. Seldin (Author), Roger H. Reeves (Author), G. William Wong (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CTRP13 ablation improves systemic glucose and lipid metabolism
by: Fangluo Chen, et al.
Published: (2023) -
The use of mouse models to understand and improve cognitive deficits in Down syndrome
by: Ishita Das, et al.
Published: (2011) -
Immune Dysregulation in Children With Down Syndrome
by: Dean Huggard, et al.
Published: (2020) -
Declining muscle NAD+ in a hyperandrogenism PCOS mouse model: Possible role in metabolic dysregulation
by: Ali Aflatounian, et al.
Published: (2022) -
Dysregulation of sphingolipid metabolism in pain
by: Jianfeng Wang, et al.
Published: (2024)